US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 3.1900
  • +0.1300+4.25%
Close Dec 31 16:00 ET
  • 3.1800
  • -0.0100-0.31%
Post 20:01 ET
215.60MMarket Cap-2.14P/E (TTM)

Perspective Therapeutics Key Stats

Perspective Therapeutics Q3 2024 Earnings Date

Currency:USDNov 12, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.19
-0.21
-0.02
Miss Est.
+52.14%
+43.24%
-9.72%
Net Income
--
-15.12M
--
-46.02%
Strong Buy

Dec 31, 2024

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 151.330K--
--2024/Q4-- / 257.760K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 151.330K--
--2024/Q4-- / 257.760K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    88.89%
  • Hold

    11.11%
  • Sell

    0.00%

Price Target

No Data